Login

Blackstone locks in $765 million refinance for fully leased Boston life science building

Deal comes as national biotech market has weakened
The Center for Life Science is 100% occupied and leased almost entirely to investment-grade medical and research institutions. (CoStar)
The Center for Life Science is 100% occupied and leased almost entirely to investment-grade medical and research institutions. (CoStar)

Blackstone, through its BioMed Realty subsidiary, has secured refinancing for the fully leased Center for Life Science laboratory and office tower in Boston with a $765 million commercial mortgage-backed securities loan.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE